Tag Archives: Type I Diabetes

T1D Therapeutics: Two Health Transformers Tackle Type 1 Diabetes at the Source

September 6, 2024Business, Health, Innovation, StartupsAmerican Diabetes Association, diabetes, Health Moonshot, Health Transformer, Health Transformers, Innovation, Logan Plaster, Mike Moradi, Sensulin, T1D, T1D Moonshot, Type 1 Diabetes, Type 1 Diabetes Moonshot, Type I Diabetes, Warren Marcus, Wink TherapeuticsNicole Kinsey

Podcast: Play in new window | Download (19.6MB)

Join StartUp Health NOW for a groundbreaking episode exploring the latest advancements in Type 1 diabetes research. We delve into our T1D Moonshot Community dedicated to improving detection, management, and treatment of the disease, and uncover promising developments on the therapeutic front.

Hear from leading innovators:

Warren Marcus, PhD, CEO & Founder of WiNK Therapeutics, shares insights on his mission to cure Type 1 diabetes using the body’s own beta islet cells.
Mike Moradi, CEO & Co-founder of Sensulin, discusses the creation of a glucose-responsive insulin for personalized diabetes management.

Discover:

The cutting-edge technologies shaping the future of Type 1 diabetes treatment
The progress being made towards a potential cure
The impact these innovations can have on the lives of people with diabetes

This episode is a must-listen for anyone interested in diabetes research, healthcare innovation, and the inspiring work of entrepreneurs making a difference.

Innovating in Alzheimer’s disease? Learn how you can join our Alzheimer’s Moonshot.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Mission Aligned: Helmsley Charitable Trust and StartUp Health on T1D Moonshot

January 26, 2024Business, Health, Innovation, StartupsDavid Panzirer, diabetes, Diabetes Moonshot, Helmsley, Helmsley Charitable Trust, Logan Plaster, T1D, T1D Moonshot, Type 1 Diabetes, Type 1 Diabetes Moonshot, Type I DiabetesNicole Kinsey

Podcast: Play in new window | Download (16.3MB)

Welcome back to StartUp Health NOW, the podcast where we hear directly from the entrepreneurs and innovators who are transforming health.

Typically on this show we talk to founders of startups. We’re all about understanding what’s new and next in health, and that often means talking to the people who are in the early days of creating a product or business. Most early-stage startups – healthcare or otherwise – have one thing in common. They need money. It takes a long time to get a healthcare business profitable, and so founders need outside funds to get an idea off the ground, complete their research, or scale up.

That brings us to this week’s guest, David Panzirer, Trustee at the Helmsley Charitable Trust. To put it in simple startup terms, David is a funder. The Helmsley Charitable Trust is an $8 billion dollar philanthropy renowned for its work funding healthcare research and innovative programs.

Of course David’s a lot more than a funder. He’s a father, for one thing, a fact that’s driven his work more than anything else. David’s also a firebrand and an instigator in an industry that often needs a little push in the right direction.

The reason for our interview, which took place at a recent health tech event, is that the Helmsley Charitable Trust has been the anchor partner for StartUp Health’s Type 1 Diabetes Moonshot, and David has been instrumental in getting that effort off the ground. He’s been part of our T1D Impact Board and has met with founders on multiple occasions to give them invaluable feedback and advice.

In this episode, we talk about the wild west of conversational AI, promising new T1D therapeutics, rural medicine, and why Helmsley has positioned itself as a high risk/high reward funder.

Let’s get into it.

Passionate about Type 1 diabetes? Contact us to learn how you can join our T1D Moonshot.

Innovating in Alzheimer’s disease? Contact us to learn how you can join our Alzheimer’s Moonshot.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Innovators: Health Transformer University fuels your health moonshot

Funders: Become a Health Moonshot Champion

Why the CEO of the American Diabetes Association (ADA) Joined StartUp Health’s Health Moonshot Impact Board

January 4, 2024Business, Health, Innovation, StartupsADA, American Diabetes Association, Chuck Henderson, diabetes, Diabetes Moonshot, Health Moonshot, Health Moonshots, Logan Plaster, StartUp Health, T1D, T1D Moonshot, Type 1 Diabetes, Type 1 Diabetes Moonshot, Type I DiabetesNicole Kinsey

Podcast: Play in new window | Download (27.0MB)

Since 2020, Charles “Chuck” Henderson has led the American Diabetes Association (ADA) as CEO. In 2023, he joined StartUp Health’s Health Moonshot Impact Board, a unique, multi-disciplinary group of stakeholders passionate about advancing health innovation. On the Health Moonshot Impact Board, Henderson joins top thought leaders like Dr. Toby Cosgrove (former CEO, Cleveland Clinic) and Sue Siegel (former CEO, GE Ventures).

In this StartUp Health NOW episode, StartUp Health’s Logan Plaster sat down with Henderson to learn about his priorities in leading the ADA and why it was important to him to join StartUp Health’s moonshot community.

Innovators: Health Transformer University fuels your health moonshot

Funders: Become a Health Moonshot Champion
Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content.
Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Looking to break down health barriers? If you’re an entrepreneur or investor, contact us to learn how you can join our Health Equity Moonshot.
Passionate about Type 1 diabetes? If you’re an entrepreneur or investor, contact us to learn how you can join our T1D Moonshot.

David Weingard Breaks Down the Mission and Vision of StartUp Health’s New T1D Moonshot

July 12, 2022Business, Health, Innovation, StartupsCecelia Health, David Weingard, diabetes, Diabetes Moonshot, Health Moonshot, StartUp Health, T1D, T1D Moonshot, Type 1 Diabetes, Type 1 Diabetes Moonshot, Type I DiabetesNicole Kinsey

Podcast: Play in new window | Download (Duration: 19:51 — 18.2MB)

This week’s episode is a conversation with a very special guest, David Weingard. For years StartUp Health backed his work as a founder as he built up a startup called Cecelia Health that provides a combination of high-tech and high-touch care for people with diabetes. Now David is leading a new initiative here at StartUp Health, the Type 1 Diabetes Moonshot. As the Chief Impact Officer, David has brought together an all-star team of T1D advocates to further this moonshot by onboarding investors, entrepreneurs, and researchers who are building the future of health. Hear how the Type 1 Diabetes Moonshot Impact Board is breaking down silos and speeding up innovation — and how you can join the effort.

Entrepreneurs, are you working on a T1D solution? We want to hear from you.
Investors, want to back an impact-driven fund laser focused on T1D? Contact us.

Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content.
Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.